Astrazeneca vaccine hopes give investors a shot in the arm on first trading day of 2021 By Francesca Washtell For The Daily Mail Published: 21:50 GMT, 4 January 2021 | Updated: 21:50 GMT, 4 January 2021 Stock markets started the new year with a bang as high hopes for Astrazeneca’s vaccine fuelled a rally on … Read more
Today, 82-year-old dialysis patient Brian Pinker became the first person to receive the vaccine created by Oxford University and AstraZeneca. Getting the jab into a patient’s arm is just the final stage of a complicated manufacturing process beginning with a single cell. Some 530,000 doses of the Oxford coronavirus vaccine will be available for vulnerable people … Read more
Questions are being asked over the speed at which the UK managed to approve the ‘game-changing’ Oxford University/AstraZeneca jab. Yesterday, Britain became the first and only country to give the go ahead for the use of the vaccine, following rigorous trials which found no-one who was given the jab became seriously ill. Dr June Raine, … Read more
Astrazeneca boss damns critics of £29bn deal to buy Alexion, pledging it will propel company to top of FTSE 100 By Daily Mail City & Finance Reporter Published: 21:50 GMT, 27 December 2020 | Updated: 21:50 GMT, 27 December 2020 Astrazeneca’s chief executive has damned critics of his £29billion deal to buy Alexion, pledging it … Read more
Oxford’s coronavirus vaccine on track to be approved ‘shortly after Christmas’, top scientist says as he says study data looks ‘better than ever’ UK regulator the MHRA has been analysing study data since November 27 Testing suggests the vaccine is either 62% or 90% effective, depending on doses Either dosing regime looks good enough for … Read more
Astrazeneca to take out £13bn bridging loan to finance blockbuster takeover of US giant Alexion Pharmaceuticals By Daily Mail City & Finance Reporter Published: 21:51 GMT, 13 December 2020 | Updated: 21:51 GMT, 13 December 2020 Astrazeneca will take out a £13billion bridging loan to finance its blockbuster takeover of US giant Alexion Pharmaceuticals. The … Read more
U.S. doctors are worried that their patients won’t return to get a second dose of coronavirus vaccine if the Centers for Disease Control and Prevention (CDC) doesn’t give them a clear, upfront warning that none of the shots will be a ‘walk in the park.’ ‘As a practicing physician, I have got to be sure … Read more
Dosing ERROR by researchers in the AstraZeneca-Oxford University vaccine trial boosted its success rate to 90%, firm’s vice-president reveals AstraZeneca scientist Mene Pangalos says ‘serendipity,’ led to a break through ‘Mistake’ helped scientists discover half-dose was more effective than a full one More analysis needed to explain why an initial lower dose was more effective … Read more
Stocks storm higher after trials show coronavirus vaccine developed by Astrazeneca and Oxford University could be 90% effective By Hugo Duncan And Lucy White For The Daily Mail Published: 22:07 GMT, 23 November 2020 | Updated: 22:07 GMT, 23 November 2020 Travel, oil and leisure stocks stormed higher after trials showed the coronavirus vaccine developed … Read more
A ‘thrilled’ Prince William has congratulated the Oxford University team who did ten years of work in just ten months to make a Covid vaccine that is 90 per cent effective. The Duke of Cambridge hailed the team’s ‘amazing achievement’ in a Zoom callfrom Kensington Palace this morning and said: ‘Well done, I’m so pleased for … Read more